Ryman: I think Phase 2 is running now,
at least on B cell MM malignancies with CLR131 AND Dexamethasone:
"...In addition, the company plans to initiate a Phase II clinical study to assess efficacy in a range of B-cell malignancies in the first quarter of 2017..."
Anyway, I saw mention from the company this year that they had their first patient recruited in January, and thought it said for Phase 2 trial mentioned above. With relapsed MM you do not wait to get more recruits to all start together. You get started!
Correct me if I am wrong...